Multicenter randomized phase III trial of Epirubicin plus Paclitaxel vs Epirubicin followed by Paclitaxel in metastatic breast cancer patients: focus on cardiac safety

✍ Scribed by Baldini, E; Prochilo, T; Salvadori, B; Bolognesi, A; Aldrighetti, D; Venturini, M; Rosso, R; Carnino, F; Gallo, L; Giannessi, P

• Book ID: 109998097
• Publisher: Nature Publishing Group
• Year: 2004
• Tongue: English
• Weight: 101 KB
• Volume: 91
• Category: Article
• ISSN: 0007-0920
• DOI: 10.1038/sj.bjc.6601883